Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    Open Studies | "Gout"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Gout"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Gout: Allopurinol vs. Febuxostat
Conditions: Gout;   Chronic Kidney Diseases
Interventions: Drug: Allopurinol;   Drug: Febuxostat;   Drug: Placebo, vehicle control (Febuxostat-shaped);   Drug: Placebo, vehicle control (Allopurinol-shaped)
2 Unknown  Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
3 Recruiting Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study
Conditions: Gout;   Chronic Kidney Diseases
Interventions: Drug: Anakinra 100mg and Placebo Depo-Medrone;   Drug: Depo-Medrone 120mg and Placebo (Anakinra)
4 Recruiting Novel Methods for Ascertainment of Gout Flares -A Pilot Study
Condition: Gout
Interventions: Device: IVR (Phone call);   Device: RheumPro (Smartphone application)
5 Not yet recruiting SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO 2 Study
Conditions: Gout;   Low Medication Adherence;   Health Related Quality of Life
Intervention: Behavioral: Improvement of Medication Adherence
6 Recruiting Colchicine Or Naproxen Treatment for ACute gouT
Condition: Gout
Interventions: Drug: Low-dose colchicine;   Drug: Naproxen
7 Not yet recruiting Study of URC102 to Assess the Safety and Efficacy in Gout Patients
Conditions: Gout;   Hyperuricemia
Interventions: Drug: URC102;   Drug: Placebo
8 Recruiting Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
Conditions: Gout;   Hyperuricemia
Interventions: Drug: URC102 0.25mg;   Drug: URC102 0.5mg;   Drug: URC102 1.0mg;   Drug: URC102 2.0mg;   Drug: placebo
9 Unknown  The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Syndrome;   Endothelial Dysfunction;   Hyperuricemia;   Gout;   Metabolic Syndrome
10 Recruiting Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Condition: Chronic Gout
Intervention: Biological: pegloticase
11 Recruiting A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: AC-201;   Drug: Febuxostat
12 Not yet recruiting Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions
Condition: Gout
Intervention: Drug: Denosumab
13 Recruiting Elastography as Gouty Arthropathy Outcome (EGO)
Condition: Gout
14 Recruiting Genetics of Hyperuricemia Therapy in Hmong
Condition: Hyperuricemia, Gout
Intervention: Drug: Allopurinol
15 Recruiting Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect
Condition: Gout
Intervention: Biological: Pegloticase
16 Unknown  Rheumatology Informatics System for Effectiveness
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Gout
17 Unknown  Impact of Unapproved Drug Initiative on Colchicine Use
Condition: Gout
18 Recruiting Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels
Condition: Gout
Interventions: Drug: SEL-110;   Biological: SEL-212;   Biological: SEL-037
19 Recruiting Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
Condition: Gout
Intervention: Drug: Febuxostat
20 Recruiting Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Scleroderma;   Spondylitis;   Gout;   Spinal Disease;   Chondrocalcinosis

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years